date,title,source
Oct-17-18,Research shows high positive rate for risk of hereditary disease in study of proactive genetic health screening for healthy people,PR Newswire
Oct-24-18,"Invitae to announce third quarter 2018 financial results on November 7, 2018",PR Newswire
Oct-25-18,"Report: Exploring Fundamental Drivers Behind Invitae, Aerie Pharmaceuticals, Gevo, Global Medical REIT, Cyclacel Pharmaceuticals, and Toll Brothers  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Oct-29-18,Invitae expands work with Alnylam Pharmaceuticals to provide access to genetic testing for primary hyperoxaluria,PR Newswire
Oct-31-18,Invitae (NVTA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release,Zacks
